BioPlus Acquisition Corp.


About BioPlus Acquisition Corp.

BioPlus Acquisition Corp. is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It is focused on identifying an opportunity in the life sciences industry across the US, EU, Israel, and Australasia(1)

Our leadership and board differentially consists of recognized industry leaders, including CEOs, CFOs, COOs, CSOs, Auditors, Investors, Bankers and experts covering all functional disciplines needed to maximize the value creation opportunity for a life sciences company. We bring over 200 years of collective experience in: 1) Identifying, developing and marketing value creating biotech assets, 2) Private and public company financing and dealmaking, 3) Audit and accounting, and 4) Advisory and board experience. We believe our team has demonstrated commitment to building valuable assets and can be leveraged as true long-term partners who can help maximize the value creation opportunity for a potential business combination.

"We are focused on the life sciences industry across the US, EU, Israel and Australasia(1), where we have deep clinical, regulatory, operational and commercial expertise. Furthermore, we believe our management team and board’s extensive experience positions us to be therapeutic area agnostic. We plan to identify and assess target assets leading to an efficient pathway to a merger."

Ross Haghighat, CEO & CFO

(1) Excluding China, Hong Kong and Macau